Skip to main content
. 2021 May 25;194(1):120–131. doi: 10.1111/bjh.17499

Fig 3.

Fig 3

Progression‐free survival in cytogenetic subgroups. a ≥ 1 of del(17p), t(4;14) or t(14;16) at study entry. CI, confidence interval; d, dexamethasone; Isa, isatuximab; P, pomalidomide; PFS, progression‐free survival.